Clinical Trials Sponsored by Sally Falk

Total 250 results

Sally Falk

Completed

Visual Feedback With Optical Sensing - A Feasibility Study (ROSS-LC)

Lung Cancer

United Kingdom
Sally Falk

Unknown

Simultaneous CBCT Acquisition During Arc Radiotherapy (SCART)

Lung Cancer | Prostate Cancer

United Kingdom
Sally Falk
University of Manchester

Unknown

Oxygen Enhanced MRI Measurement in Head and Neck Cancer: Validation and Efficacy of Response.

Head and Neck Cancer
Sally Arai

Completed

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

Leukemia | Multiple Myeloma

United States
Dr. Falk Pharma GmbH

Recruiting

Different Doses of ZED1227 vs. Placebo in NAFLD (NormaliZED)

NAFLD | Liver Fibrosis

Germany
Dr. Falk Pharma GmbH

Recruiting

Norursodeoxycholic Acid vs. Placebo in NASH

Nonalcoholic Steatohepatitis

Austria
Dr. Falk Pharma GmbH

Completed

Mesalazine Oral Suspension in Active Eosinophilic Esophagitis

Eosinophilic Esophagitis

Switzerland
Dr. Falk Pharma GmbH

Completed

Budesonide for Induction of Remission in Incomplete Microscopic Colitis

Incomplete Microscopic Colitis

Germany, Sweden
Dr. Falk Pharma GmbH

Terminated

Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis

France, Germany
Dr. Falk Pharma GmbH

Completed

Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis

Proctitis

Germany
Dr. Falk Pharma GmbH

Completed

Pharmacokinetic Investigation of UDCA in Bile and Serum

Healthy

Netherlands
Dr. Falk Pharma GmbH

Terminated

Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis

Radiation Proctitis

Germany
Sally Ibbotson

Completed

Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer

Non-melanoma Skin Cancer
Dr. Falk Pharma GmbH

Recruiting

Different Doses of Naronapride vs. Placebo in Gastroparesis (MOVE-IT)

Gastroparesis

Belgium
Dr. Falk Pharma GmbH

Completed

Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) (PROTECT-2)

Ulcerative Colitis

Germany
Dr. Falk Pharma GmbH

Completed

Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

Germany
Dr. Falk Pharma GmbH

Completed

Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis

Autoimmune Hepatitis

Germany
Dr. Falk Pharma GmbH

Completed

Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis

Uncomplicated Diverticulitis

Germany
Dr. Falk Pharma GmbH

Terminated

Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis

Diverticulitis

Germany
Dr. Falk Pharma GmbH

Terminated

Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis (PROTECT-1)

Ulcerative Colitis

Germany
Dr. Falk Pharma GmbH

Completed

Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis (NUC-3)

Primary Sclerosing Cholangitis

Austria, Germany, Norway
Dr. Falk Pharma GmbH

Completed

Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)

Oral Chronic Graft vs Host Disease

Germany, Israel
Dr. Falk Pharma GmbH

Completed

Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis

Eosinophilic Esophagitis

Germany
Dr. Falk Pharma GmbH

Completed

9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease

Crohn´s Disease

Germany
Dr. Falk Pharma GmbH

Completed

Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)

Crohn's Disease

Germany
Dr. Falk Pharma GmbH

Completed

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis

Collagenous Colitis

Germany
Dr. Falk Pharma GmbH

Completed

Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)

Colitis, Ulcerative

Germany
Dr. Falk Pharma GmbH

Completed

Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine

Crohn's Disease

Austria, Germany
Dr. Falk Pharma GmbH

Completed

Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)

Recurrence | Colitis, Ulcerative

Germany
Dr. Falk Pharma GmbH

Recruiting

norUrsodeoxycholic Acid vs Placebo in PSC

Primary Sclerosing Cholangitis

Austria, Germany
Dr. Falk Pharma GmbH

Completed

Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis (EOS-2)

Eosinophilic Esophagitis

Germany
Dr. Falk Pharma GmbH

Completed

Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea (ERASE)

Traveler's Diarrhea

Ecuador, Guatemala, India
Dr. Falk Pharma GmbH

Completed

Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis

Lymphocytic Colitis

Germany
Dr. Falk Pharma GmbH

Completed

Budesonide 9 mg Capsules in Active UC (TOPICAL-1)

Colitis, Ulcerative

Germany
Dr. Falk Pharma GmbH

Terminated

Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis

Diverticulitis

United States
Dr. Falk Pharma GmbH

Completed

Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis (EOS-1)

Eosinophilic Esophagitis

Germany
Dr. Falk Pharma GmbH

Completed

TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)

Active Ulcerative Colitis

Germany
Dr. Falk Pharma GmbH

Completed

Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study

Colonic Diverticulosis

Germany
Dr. Falk Pharma GmbH

Completed

OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis

Ulcerative Colitis

Germany
Dr. Falk Pharma GmbH

Completed

Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease (TRUST-2)

Crohn´s Disease

Germany
Sally CHAN

Completed

Digital Buddy : Digital Inclusion for the Elderly

Mental Wellbeing of Older Adults

Hong Kong
Sally E. Wenzel MD

Completed

Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma (SARPIII)

Asthma | Severe Persistent Asthma

United States
Sally E. Wenzel MD

Completed

Electrophilic Fatty Acid Derivatives in Asthma (EFADA)

Asthma | Electrophilic Fatty Acids

United States
Centro Universitario La Salle

Completed

TDCS Effects on Motor Learning and Motor Control in Healthy Subjetcs

Healthy

Spain
Centro Universitario La Salle

Unknown

Complex Motor Learning With Motor Imaginary

Learning Disturbance

Spain
Centro Universitario La Salle

Completed

Action Mechanisms of Shock Waves on Pain

Asymptomatic Condition

Spain
Centro Universitario La Salle

Completed

Effects of Low Versus High Frequency Percutaneous Electrical Nerve Stimulation on Chronic Neck Pain Patients.

Chronic Pain | Neck Pain | Myofascial Pain Syndrome

Spain
Falu Hospital

Completed

Feasibility of Sending a Direct Send HPV Self-sampling Kit to Long-term Screening Non-attenders

Cervical Cancer | HPV

Sweden
Falu Hospital

Completed

Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination

Cervical Cancer | HPV

Sweden
Rafa Laboratories
Dr. Falk Pharma GmbH

Completed

Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

Graft Vs Host Disease

Israel

3

Subscribe